HLA-E is normally expressed at low levels, but its expression increases on the surface of most tumor cells, thereby inducing a cascade of inhibitory signals that hinder NK cytotoxic activity and cytokine secretion (16–19). The gene discussed is HLA-E; the disease is neoplasm.